ArticleJournal of family medicine and primary care2026
Hemostatic imbalances in chronic kidney disease: A regional perspective from Bihar.
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives of the Study: To evaluate platelet indices and basic blood coagulation parameters in various stages of CKD patients and to find out any correlation between patients' coagulation parameters and CKD staging. Materials and Methods: It was a 2-year prospective observational study conducted in the Department of Hematology in a tertiary care hospital. Sample size was 160, out of which 80 were cases and 80 were age and gender matched controls. Patients of both sexes and age group ranging ≥20 years belonging to various stages of non-dialyzed CKD were included in the study. Platelet parameters studied were platelet count and platelet indices like Mean platelet volume (MPV) or platelet distribution width (PDW) and coagulation parameters studied were Prothrombin time (PT), International normalized ratio (INR), activated partial thromboplastin time (aPTT), Fibrin degradation products (FDP), D-dimer and fibrinogen. Statistical Analysis: The data obtained was be analyzed by using SPSS version 25 software. The results were expressed as the mean ± SD for continuous data and as percentage or frequency for categorical data. Results: The most common agegroup of CKD patients was found out to be 51-60 years (34.5%). Most common clinical feature with which patients presented to the clinic was weakness and lethargy (41.2%). Majority of the patients belonged to CKD stage III (51.2%) followed by CKD. The most common cause of CKD was diabetic nephropathy (33.1%), followed by hypertensive nephropathy (25.6%). Mean Platelet count was lowest in CKD stage 5 (0.96 ± 0.11 × 10 Conclusion: Monitoring of primary and secondary hemostatic parameters is of utmost importance in predicting bleeding and thrombotic risks in CKD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.